Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.71%
1,092.80
-7.77
-0.71%
—1,100.571,098.941,103.801,084.24——
SIXC
Communications
SIXC
Communications
SIXC
-0.07%
604.74
-0.41
-0.07%
—605.15605.15606.69602.76——
SIXE
Energy
SIXE
Energy
SIXE
+1.64%
1,214.80
+19.61
+1.64%
—1,195.191,204.711,221.691,204.71——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,724.57
-15.34
-0.88%
—1,739.911,734.501,734.501,710.67——
SIXM
Financials
SIXM
Financials
SIXM
+0.14%
639.43
+0.87
+0.14%
—638.56640.21645.32638.69——
SIXR
Staples
SIXR
Staples
SIXR
+0.91%
839.15
+7.58
+0.91%
—831.57840.48844.16834.54——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.06%
215.62
+2.26
+1.06%
—213.36213.36215.79212.77——
SIXT
Technology
SIXT
Technology
SIXT
-1.69%
3,179.52
-54.66
-1.69%
—3,234.183,171.863,195.363,145.46——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.13%
936.91
+1.26
+0.13%
—935.65937.31941.44933.16——
SIXV
Health care
SIXV
Health care
SIXV
+0.24%
1,452.77
+3.51
+0.24%
—1,449.261,454.771,462.651,447.95——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,365.18
-17.27
-0.72%
—2,382.452,371.192,380.452,362.86——
RGEN:NASDAQ
Repligen Corp
$117.43
-0.73%
(-0.86) 1D
$117.43
0.00% (0.00)
After hours
Closed: Apr 28, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RGEN...
Open
$118.28
High
$118.79
Low
$114.85
Mkt. cap
6.62B
Avg. vol.
904.85K
Volume
0.00
P/E ratio
135.84
52-wk high
$175.77
52-wk low
$109.66
EPS
$0.86
Beta
1.19
Shares outstanding
56.40M
No. of employees
2K
News stories
From sources across the web
Profile
Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs. The company is based in Waltham, Massachusetts, and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biopharmaceutical drug developers and contract development and manufacturing organizations worldwide. Wikipedia
About Repligen Corp
CEOTony J. Hunt
Employees2K
Founded1981
HeadquartersWaltham, Massachusetts, United States
SectorHealth care
Websiterepligen.com
Last report
Feb 24, 2026
Fiscal Period
Q4 2025
Normalized EPS / Estimate
0.49/ (0.44 est.)USD
+10.38%beat
Revenue / Estimate
197.91M/ (192.23M est.)USD
+2.96%beat
Fiscal Q4 2025 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
169.17M
182.37M
188.80M
197.91M
Cost of goods sold
77.80M
89.37M
88.29M
94.08M
Cost of revenue
77.80M
89.37M
88.29M
94.08M
Research and development expenses
12.11M
13.97M
14.18M
13.12M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
69.81M
69.41M
73.66M
74.36M
Operating expense
81.92M
83.38M
87.84M
87.48M
Total operating expenses
159.72M
172.75M
176.13M
181.56M
Operating income
9.45M
9.62M
12.68M
16.35M
Other non operating income
-286.00K
3.50M
-446.00K
-11.48M
EBT including unusual items
7.94M
18.22M
17.11M
19.11M
EBT excluding unusual items
10.82M
13.94M
12.96M
17.59M
Income tax expense
2.11M
3.35M
2.20M
5.83M
Effective tax rate
26.60%
18.39%
12.86%
30.48%
Other operating expenses
-
-
-
-
Net income
5.83M
14.87M
14.91M
13.29M
Net profit margin
3.45%
8.15%
7.90%
6.71%
Earnings per share
0.39
0.37
0.46
0.49
Interest and investment income
7.31M
6.58M
6.92M
6.75M
Interest expense
-5.66M
-5.77M
-5.83M
-5.91M
Net interest expenses
1.65M
817.00K
1.09M
842.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
28.16M
29.70M
32.69M
36.30M
Gain or loss from assets sale
1.22M
2.16M
-3.38M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer